Showing results (21-30 of 1,308) with videos related to

Sort By:
Pageof 131
International Journal of Cardiology|April 18, 2009
Transatlantic similarities and differences in major natural history endpoints of heart failure after acute myocardial infarction: a propensity-matched study of the EPHESUS trialBertram Pitt, Faiez Zannad, Mihai Gheorghiade, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|June 29, 2019
Determinants of anti-fibrotic response to mineralocorticoid receptor antagonist therapy: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) and Early Eplerenone Treatment in Patients with Acute ST-elevation Myocardial Infarction without Heart Failure (REMINDER) trialsSusan Stienen, Patrick Rossignol, António Barros, et al.
Journal of Cardiac Failure|May 19, 2025
Mineralocorticoid Receptor Antagonists and Aldosterone Synthase Inhibitors: Agent Comparison With Implications for Clinical Practice and Trial DesignJoão Pedro Ferreira, Pedro Marques, Ana Rita Leite, et al.
American Heart Journal|December 12, 2017
Mineralocorticoid receptor antagonists in patients with acute myocardial infarction - A systematic review and meta-analysis of randomized trialsMatthias Bossard, Yasser Binbraik, Farzin Beygui, et al.
American Journal of Hypertension|December 12, 2017
Spironolactone and Resistant Hypertension in Heart Failure With Preserved Ejection FractionPatrick Rossignol, Brian Lee Claggett, Jiankang Liu, et al.
European Heart Journal|March 3, 2020
Myocardial reperfusion reverses the J-curve association of cardiovascular risk and diastolic blood pressure in patients with left ventricular dysfunction and heart failure after myocardial infarction: insights from the EPHESUS trialMichael Böhm, João Pedro Ferreira, Felix Mahfoud, et al.
European Heart Journal|January 7, 2011
Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trialBertram Pitt, Stefan D Anker, David A Bushinsky, et al.
The American Journal of Cardiology|September 29, 2016
Prognostic Value of the Thrombolysis in Myocardial Infarction Risk Score in ST-Elevation Myocardial Infarction Patients With Left Ventricular Dysfunction (from the EPHESUS Trial)Batric Popovic, Nicolas Girerd, Patrick Rossignol, et al.
Journal of the American College of Cardiology|October 23, 2012
Influence of baseline and worsening renal function on efficacy of spironolactone in patients With severe heart failure: insights from RALES (Randomized Aldactone Evaluation Study)Orly Vardeny, Dong Hong Wu, Akshay Desai, et al.
The American Journal of Cardiology|December 23, 2008
Effectiveness of digoxin in reducing one-year mortality in chronic heart failure in the Digitalis Investigation Group trial, Ali Ahmed, Finn Waagstein, et al.
Pageof 131